Join the club for FREE to access the whole archive and other member benefits.

Synthetic Nanobots Could End Antibiotic Resistance


Key points from article :

Most current antibiotics wipe out all bacteria - good and bad.

French startup Eligo Bioscience is creating genetically engineered biological nanobots.

Made of synthesized DNA and protein they could specifically target resistant bacteria.

Nanobots would be inactive until they made their way to the gut.

Use CRISPR gene editing enzyme to scan bacterial DNA and identify their target.

Could be used as a prophylactic drug.

More testing needed before trying in humans by 2020.

Mentioned in this article:

Click on resource name for more details.

Centers for Disease Control and Prevention (CDC)

National public health institute of the United States.

Eligo Bioscience

Synthetic Biology company for targeted antimicrobials and microbiome editing.

Xavier Duportet

CEO at Eligo Bioscience.